UBS Group’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $201K | Sell |
42,800
-3,558
| -8% | -$16.7K | ﹤0.01% | 5478 |
|
|
2025
Q1 | $169K | Buy |
46,358
+8,863
| +24% | +$32.4K | ﹤0.01% | 5405 |
|
|
2024
Q4 | $177K | Buy |
37,495
+25,565
| +214% | +$121K | ﹤0.01% | 5327 |
|
|
2024
Q3 | $111K | Buy |
11,930
+4,239
| +55% | +$39.5K | ﹤0.01% | 5093 |
|
|
2024
Q2 | $44.2K | Sell |
7,691
-12,683
| -62% | -$72.9K | ﹤0.01% | 5636 |
|
|
2024
Q1 | $137K | Sell |
20,374
-3,007
| -13% | -$20.2K | ﹤0.01% | 4931 |
|
|
2023
Q4 | $151K | Buy |
23,381
+12,945
| +124% | +$83.5K | ﹤0.01% | 4760 |
|
|
2023
Q3 | $52.2K | Sell |
10,436
-1,895
| -15% | -$9.48K | ﹤0.01% | 5140 |
|
|
2023
Q2 | $86.8K | Buy |
12,331
+4,672
| +61% | +$32.9K | ﹤0.01% | 5072 |
|
|
2023
Q1 | $47.5K | Buy |
7,659
+2,612
| +52% | +$16.2K | ﹤0.01% | 5415 |
|
|
2022
Q4 | $32.2K | Buy |
+5,047
| New | +$32.2K | ﹤0.01% | 5998 |
|
|
2022
Q2 | – | Sell |
-2,923
| Closed | -$45K | – | 9382 |
|
|
2022
Q1 | $45K | Sell |
2,923
-3,970
| -58% | -$61.1K | ﹤0.01% | 5575 |
|
|
2021
Q4 | $158K | Buy |
+6,893
| New | +$158K | ﹤0.01% | 4840 |
|
|
2021
Q2 | – | Sell |
-2,136
| Closed | -$28K | – | 8345 |
|
|
2021
Q1 | $28K | Sell |
2,136
-112
| -5% | -$1.47K | ﹤0.01% | 6049 |
|
|
2020
Q4 | $46K | Buy |
+2,248
| New | +$46K | ﹤0.01% | 5263 |
|